Yaxiang Co., Ltd. announced that the 20th meeting of the third board of directors will be held on November 20, 2024. The meeting reviewed and approved the proposal on the completion of the fundraising projects for the initial public offering of stocks and the permanent supplement of remaining raised funds to working capital, agreeing to complete the fundraising project "Yaxiang Biotechnology Co., Ltd. Production Base Project" and permanently supplement the remaining raised funds of 1.6717 million yuan to working capital. At the same time, the company also reviewed and approved the proposal to establish a subsidiary in the usa, agreeing to set up a wholly-owned subsidiary in Delaware, usa with its own funds. In addition, the company reviewed and approved the proposal to provide guarantees for the holding subsidiary, agreeing to provide a joint liability guarantee of no more than 48 million yuan for the credit limit application of 40 million yuan from the holding subsidiary Wuxue Glamer Biotechnology Co., Ltd. to the Suzhou branch of china citic bank corporation.